Cardiodoron® Dilution Wirkstoffe: Ethanol. Digestio aus Onopordum acanthium mit Hyoscyamus niger Ø clinical trials

A parallel-group low-intervention, phase IV, randomized, double-blind, placebo-controlled, single-center, national, two-arm trial to investigate efficacy and safety of Cardiodoron® in patients with functional cardiovascular disorders (FCD)

This study is looking at a medicine called Cardiodoron to see if it helps people with heart-related symptoms, often called functional cardiovascular disorders. It compares Cardiodoron to a dummy pill (placebo) to check its effects and safety in adults in the UK.